5 February 2020 in Middle East Fertility Society Journal
Background: The use of assisted reproductive technology (ART) is increasing worldwide, and observational studies have indicated that women who conceived by ART have an increased risk of pregnancy complications including gestational diabetes mellitus (GDM). We aimed to determine the risk of GDM among women who conceived with ART by systematic review and meta-analysis. Main text: A systematic literature search was conducted in ISI Web of Knowledge, MEDLINE, Scopus, and Embase through May 2017 for English-language articles using a list of keywords. All studies comparing GDM in women conceived by ART and those who conceived spontaneously were included. Data extraction was performed by two authors independently and discrepancies were resolved by discussion. In total, 48 studies with 91,487 pregnancies conceived through ART and 2,525,234 spontaneously conceived met the inclusion criteria. There was evidence of substantial heterogeneity among these studies (P < 0.001, I2 = 98.6%). Random effects meta-analysis showed a significant increase in GDM among those who conceived by ART compared with those who conceived spontaneously (pooled relative risk = 1.51, 95% confidence interval = 1.18–1.93). Visual inspection of the funnel plot did not reveal any publication bias, which was supported by Egger’s test and Begg’s test. Conclusion: The findings of this systematic review indicate that the use of ART treatment is associated with a 1.51-fold increase in GDM. Women need to be counselled carefully before undergoing ART treatment about the possibility and risk of GDM.
14 August 2020 in Journal of Renal Injury Prevention
Introduction: Endocrine disorders are one of the causes of infertility and sexual dysfunction is one of the neurological complications of diabetes. Objectives: The present study investigated the relationship between sexual function and type 2 diabetes in infertile men referring to the Royan Institute in 2019. Patients and Methods: This cross-sectional study was conducted in 2019 on 150 non-diabetic infertile men and 126 diabetic infertile men who referred to the Royan institute and were qualified in terms of research inclusion criteria. The convenience sampling method was used. The tools used to collect data include a demographic checklist, an 11-item version of Sexual Quality of Life-Male (SQOL-M), and a 15-question International Index of Erectile Function (IIEF) Questionnaire. Results: A total of 276 people were evaluated in this study. The mean age of participants was 40.98 (7.44) years in the diabetic group and 35.2 (6.08) years in the non-diabetic group. Sexual function, failure to reach ultimate pleasure, sexual desire, satisfactory sexual intercourse, overall sexual satisfaction, erectile function, as well as the standard index of sexual quality of life (SQOL-M score) showed no statistically significant difference between diabetic and non-diabetic infertile men (P> 0.05). In people with normal body mass index (BMI) and employees, the relationship between diabetes and the overall score of sexual function was statistically significant (P< 0.05). In addition, there is a significant relationship between diabetes and the SQOL-M in people under 37 years of age and people with primary infertility (P< 0.05). Conclusion: Age and BMI are the two main factors influencing sexual function. In the present study, statistical relationship of these two factors in two groups of diabetics and non-diabetic infertile men not in general but in subgroups was proved. Our investigation indicated no statistically significant relationship between the two groups of diabetic and non-diabetic infertile men in any of the factors of sexual function and the standard index of male quality of sexual life.